Entering the field of psychedelic therapy, whether as a therapist or a client, means learning about an ever-growing, sometimes bewildering array of psychedelic substances. My friends in the field have ...

Hallucinogenic compounds that activate multiple receptors, found in Colorado River toads, show “promising transdiagnostic therapeutic with rapid and lasting effects” for conditions such as depression ...

Psychedelics—frequently recognized as substances such as LSD, psilocybin, and DMT—not only alter perception, mood, and cognition, but they often cause hallucinations. That said, they have also been ...

Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, non-hallucinogenic therapeutics that can treat neurodegenerative and neuropsychiatric ...

Enveric Biosciences completed preclinical PK studies for EB-003, a DMT analog targeting depression and anxiety without hallucinations. Rat and dog studies confirmed the drug’s dose-proportional oral ...